Company
Modus Therapeutics Holding AB
Headquarters: Stockholm, Sweden
Employees: 2
OMX: MODTX
Modus Therapeutics Holding AB Categories
Sweden Healthcare BiotechnologySweden Healthcare Sweden Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $113.24 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $76.33 B |
| Marinomed Biotech AG | $56.13 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Modus Therapeutics Holding Ab, a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It is developing Sevuparin, a polysaccharide to treat patients with sepsis and septic shock. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
Stocks & Indices
Modus Therapeutics Holding AB has the following listings and related stock indices.
Stock: OMX: MODTX wb_incandescent